Literature DB >> 17339318

Interaction of hydroxylated collagen IV with the von hippel-lindau tumor suppressor.

Alexandra Grosfeld1, Ineke P Stolze, Matthew E Cockman, Christopher W Pugh, Mariola Edelmann, Benedikt Kessler, Alex N Bullock, Peter J Ratcliffe, Norma Masson.   

Abstract

The von Hippel-Lindau tumor suppressor (pVHL) targets hydroxylated alpha-subunits of hypoxia-inducible factor (HIF) for ubiquitin-mediated proteasomal destruction through direct interaction with the hydroxyproline binding pocket in its beta-domain. Although disruption of this process may contribute to VHL-associated tumor predisposition by up-regulation of HIF target genes, genetic and biochemical analyses support the existence of additional functions, including a role in the assembly of extracellular matrix. In an attempt to delineate these pathways, we searched for novel pVHL-binding proteins. Here we report a direct, hydroxylation-dependent interaction with alpha-chains of collagen IV. Interaction with pVHL was also observed with fibrillar collagen chains, but not the folded collagen triple helix. The interaction was suppressed by a wide range of tumor-associated mutations, including those that do not disturb the regulation of HIF, supporting a role in HIF-independent tumor suppressor functions.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17339318     DOI: 10.1074/jbc.M611648200

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  30 in total

1.  Proteomic dissection of the von Hippel-Lindau (VHL) interactome.

Authors:  Yanlai Lai; Meihua Song; Kevin Hakala; Susan T Weintraub; Yuzuru Shiio
Journal:  J Proteome Res       Date:  2011-10-11       Impact factor: 4.466

Review 2.  Mapping structural landmarks, ligand binding sites, and missense mutations to the collagen IV heterotrimers predicts major functional domains, novel interactions, and variation in phenotypes in inherited diseases affecting basement membranes.

Authors:  J Des Parkin; James D San Antonio; Vadim Pedchenko; Billy Hudson; Shane T Jensen; Judy Savige
Journal:  Hum Mutat       Date:  2011-02       Impact factor: 4.878

3.  Downregulation of integrins by von Hippel-Lindau (VHL) tumor suppressor protein is independent of VHL-directed hypoxia-inducible factor alpha degradation.

Authors:  Qingzhou Ji; Robert D Burk
Journal:  Biochem Cell Biol       Date:  2008-06       Impact factor: 3.626

4.  Deletion of von Hippel-Lindau in glomerular podocytes results in glomerular basement membrane thickening, ectopic subepithelial deposition of collagen {alpha}1{alpha}2{alpha}1(IV), expression of neuroglobin, and proteinuria.

Authors:  Brooke M Steenhard; Kathryn Isom; Larysa Stroganova; Patricia L St John; Adrian Zelenchuk; Paul B Freeburg; Lawrence B Holzman; Dale R Abrahamson
Journal:  Am J Pathol       Date:  2010-06-03       Impact factor: 4.307

Review 5.  Hypoxia, Hypoxia-inducible Transcription Factors, and Renal Cancer.

Authors:  Johannes Schödel; Steffen Grampp; Eamonn R Maher; Holger Moch; Peter J Ratcliffe; Paul Russo; David R Mole
Journal:  Eur Urol       Date:  2015-08-19       Impact factor: 20.096

6.  Drusen in patient-derived hiPSC-RPE models of macular dystrophies.

Authors:  Chad A Galloway; Sonal Dalvi; Sandy S C Hung; Leslie A MacDonald; Lisa R Latchney; Raymond C B Wong; Robyn H Guymer; David A Mackey; David S Williams; Mina M Chung; David M Gamm; Alice Pébay; Alex W Hewitt; Ruchira Singh
Journal:  Proc Natl Acad Sci U S A       Date:  2017-09-06       Impact factor: 11.205

7.  Cullins and cancer.

Authors:  Jennifer Lee; Pengbo Zhou
Journal:  Genes Cancer       Date:  2010-07

8.  Role of von Hippel-Lindau protein in fibroblast proliferation and fibrosis.

Authors:  Qiyuan Zhou; Annie Pardo; Melanie Königshoff; Oliver Eickelberg; G R Scott Budinger; Krishna Thavarajah; Cara J Gottardi; Jonathan Jones; John Varga; Moises Selman; Jacob I Sznajder; J Usha Raj; Guofei Zhou
Journal:  FASEB J       Date:  2011-06-03       Impact factor: 5.191

9.  EglN3 hydroxylase stabilizes BIM-EL linking VHL type 2C mutations to pheochromocytoma pathogenesis and chemotherapy resistance.

Authors:  Shuijie Li; Javier Rodriguez; Wenyu Li; Petra Bullova; Stuart M Fell; Olga Surova; Isabelle Westerlund; Danijal Topcic; Maria Bergsland; Adam Stenman; Jonas Muhr; Monica Nistér; Johan Holmberg; C Christofer Juhlin; Catharina Larsson; Alex von Kriegsheim; William G Kaelin; Susanne Schlisio
Journal:  Proc Natl Acad Sci U S A       Date:  2019-08-02       Impact factor: 11.205

10.  The von Hippel-Lindau protein pVHL inhibits ribosome biogenesis and protein synthesis.

Authors:  Wen-Ting Zhao; Cheng-Fu Zhou; Xue-Bing Li; Yun-Fang Zhang; Li Fan; Jerry Pelletier; Jing Fang
Journal:  J Biol Chem       Date:  2013-04-23       Impact factor: 5.157

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.